MC

Mayewell Capital

North America, Pennsylvania, United States, Pennsylvania Furnace

Description

Mayewell Capital is an investment firm that invests in healthcare, pharmaceuticals, and biotechnology.

Investor Profile

Mayewell Capital has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series C (50%)
  • Series Unknown (50%)

Country Focus

  • United States (50%)
  • United Kingdom (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mayewell Capital frequently co-invest with?

Capital Community Angel Investors
North America, Michigan, United States, East Lansing
Co-Investments: 1
Johnson & Johnson Robotics and Digital Solutions
North America, New Jersey, United States, New Brunswick
Co-Investments: 1
ExSight Ventures
North America, New York, United States, New York
Co-Investments: 1
AV
North America, South Carolina, United States, Charleston
Co-Investments: 1
PC
North America, New York, United States, New York
Co-Investments: 1
Michigan Capital Network
North America, Michigan, United States, Grand Rapids
Co-Investments: 1
M
North America, Michigan, United States, Ann Arbor
Co-Investments: 1
Bios Partners
North America, Texas, United States, Fort Worth
Co-Investments: 1
Biosciences Research and Commercialization Center (BRCC)
North America, Michigan, United States, Kalamazoo
Co-Investments: 1
Kaitai Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1

What are some of recent deals done by Mayewell Capital?

ThirtyFiveBio

Abingdon, Oxfordshire, United Kingdom

ThirtyFiveBio is a biotechnology agency

Biotechnology
Series UnknownApr 15, 2025
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CMar 8, 2023
Amount Raised: $15,000,000